Farms.com Home   News

New Discovery could Phase out Medications from Pig Inteestines

The most expensive part of the pig is neither the tenderloin nor the neck chop, but part of the intestine used for medicine against blood clots. There are about 2,000 pigs per kilogram of the drug heparin, which is a blood-thinning drug for millions of people. One kilogram of heparin provides medication to up to 6000 patients. In total, it is estimated that about one billion primarily Chinese slaughter pigs each year also supply intestines for the extraction and processing of heparin.

But it can cause problems for patients. When making medicines derived from animals, it does not become uniform in its chemical structure. It can cause relatively common but harmless side effects, and in very rare cases severe and life-threatening immune reactions.

Therefore, it has long been an ambition among researchers to make heparin in a laboratory to get cleaner heparin without side effects. Now researchers from the Copenhagen Center for Glycomics at the University of Copenhagen are ready with a study that shows that it is possible to make heparin without the use of animals.

“By making heparin around the animal, you get a much cleaner and more uniform chemical structure. We show that we can do it in the laboratory, i.e. in a so-called 'cell factory', in the same way as many other types of medicine are made. It is a step in the direction of the development that has also happened with insulin, which was previously extracted from the pancreas in pigs before learning to produce it in the laboratory,” says Associate Professor Rebecca Miller. She has led the study, which was published in Science Advances.

A synthetic alternative to heparin exists. However, it is difficult to dose and can lead to overdose. Therefore, GPs often prescribe animal heparin to their patients.

Contaminated heparin

Heparin is today extracted from the so-called mucosa from the pig intestine. Here, crude heparin is extracted, which then ends up as a drug in the patients.

But because of the many millions of patients who need the medicine, the size of the production is huge. This has made quality control a recurring problem for manufacturers.

In 2008, a number of stocks of heparin from Chinese pigs were recalled when it was found that the medicine was contaminated. The case ended up costing the lives of more than 100 Americans.

"Of course you want to avo

Click here to see more...

Trending Video

Intrauterine Vaccines in Swine - Dr. Heather Wilson

Video: Intrauterine Vaccines in Swine - Dr. Heather Wilson



In this episode of The Swine it Podcast Show Canada, Dr. Heather Wilson from VIDO at the University of Saskatchewan explains how intrauterine vaccination is being developed as a new option for swine health. She shares how formulation, adjuvants, and delivery methods influence immune responses and what early trials reveal about safety and reproductive performance. Listen now on all major platforms.

"The idea was that an intrauterine vaccine might avoid a tolerance response and instead create an active immune response."

Meet the guest: Dr. Heather Wilson / heather-wilson-a8043641 is a Senior Scientist and Program Manager at the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Her work centers on vaccine formulation and delivery in pigs, including the development of intrauterine vaccination to support reproductive health and passive protection of piglets. Her background spans biochemistry, immunology, and functional pathogenomics.